Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Disorder, Promiscuous Interactions, and Stochasticity Regulate State Switching in the Unstable Prostate.

Kulkarni P, Getzenberg RH.

J Cell Biochem. 2016 Oct;117(10):2235-40. doi: 10.1002/jcb.25578. Epub 2016 Jun 3.

PMID:
27152744
2.

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).

Crawford J, Prado CM, Johnston MA, Gralla RJ, Taylor RP, Hancock ML, Dalton JT.

Curr Oncol Rep. 2016 Jun;18(6):37. doi: 10.1007/s11912-016-0522-0. Review.

3.

The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer.

Liu Z, Zhu G, Getzenberg RH, Veltri RW.

J Cell Biochem. 2015 Jul;116(7):1341-9. doi: 10.1002/jcb.25091.

PMID:
25640606
4.

Navigated pelvic osteotomy and tumor resection: a study assessing the accuracy and reproducibility of resection planes in Sawbones and cadavers.

Sternheim A, Daly M, Qiu J, Weersink R, Chan H, Jaffray D, Irish JC, Ferguson PC, Wunder JS.

J Bone Joint Surg Am. 2015 Jan 7;97(1):40-6. doi: 10.2106/JBJS.N.00276.

PMID:
25568393
5.

Simulation of the recharging method of implantable biosensors based on a wearable incoherent light source.

Song Y, Hao Q, Kong X, Hu L, Cao J, Gao T.

Sensors (Basel). 2014 Nov 3;14(11):20687-701. doi: 10.3390/s141120687.

6.

An intelligent tourniquet system to stop traumatic extremity bleeding.

Kragh JF Jr, Darrah M, Gradilla C, Salinas J, Aden JK 3rd, Dubick MA.

Am J Emerg Med. 2014 Nov;32(11):1419-21. doi: 10.1016/j.ajem.2014.08.020. Epub 2014 Aug 8. No abstract available.

PMID:
25190549
7.

Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling.

Narayanan R, Ahn S, Cheney MD, Yepuru M, Miller DD, Steiner MS, Dalton JT.

PLoS One. 2014 Jul 29;9(7):e103202. doi: 10.1371/journal.pone.0103202. eCollection 2014.

8.

Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancer.

Yu EY, Getzenberg RH, Coss CC, Gittelman MM, Keane T, Tutrone R, Belkoff L, Given R, Bass J, Chu F, Gambla M, Gaylis F, Bailen J, Hancock ML, Smith J, Dalton JT, Steiner MS.

Eur Urol. 2015 Feb;67(2):334-41. doi: 10.1016/j.eururo.2014.06.011. Epub 2014 Jun 24.

PMID:
24968970
9.

Selective androgen receptor modulators as improved androgen therapy for advanced breast cancer.

Coss CC, Jones A, Dalton JT.

Steroids. 2014 Nov;90:94-100. doi: 10.1016/j.steroids.2014.06.010. Epub 2014 Jun 16. Review.

PMID:
24945109
10.

Evaluation of standard versus nonstandard vital signs monitors in the prehospital and emergency departments: results and lessons learned from a trauma patient care protocol.

Liu NT, Holcomb JB, Wade CE, Darrah MI, Salinas J.

J Trauma Acute Care Surg. 2014 Sep;77(3 Suppl 2):S121-6. doi: 10.1097/TA.0000000000000192.

PMID:
24770560
11.

Utility of vital signs, heart rate variability and complexity, and machine learning for identifying the need for lifesaving interventions in trauma patients.

Liu NT, Holcomb JB, Wade CE, Darrah MI, Salinas J.

Shock. 2014 Aug;42(2):108-14. doi: 10.1097/SHK.0000000000000186.

PMID:
24727872
12.

Toremifene for breast cancer: a review of 20 years of data.

Vogel CL, Johnston MA, Capers C, Braccia D.

Clin Breast Cancer. 2014 Feb;14(1):1-9. doi: 10.1016/j.clbc.2013.10.014. Epub 2013 Oct 31. Review.

13.

Selective androgen receptor modulators for the treatment of late onset male hypogonadism.

Coss CC, Jones A, Hancock ML, Steiner MS, Dalton JT.

Asian J Androl. 2014 Mar-Apr;16(2):256-61. doi: 10.4103/1008-682X.122339. Review.

14.

Discovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammation.

Narayanan R, Yepuru M, Coss CC, Wu Z, Bauler MN, Barrett CM, Mohler ML, Wang Y, Kim J, Snyder LM, He Y, Levy N, Miller DD, Dalton JT.

PLoS One. 2013 Dec 26;8(12):e83380. doi: 10.1371/journal.pone.0083380. eCollection 2013.

15.

Tools to identify the men with prostate cancer most appropriate for active surveillance?

Getzenberg RH.

Asian J Androl. 2014 Jan-Feb;16(1):97-8. doi: 10.4103/1008-682X.122369. No abstract available.

16.

TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.

Park K, Dalton JT, Narayanan R, Barbieri CE, Hancock ML, Bostwick DG, Steiner MS, Rubin MA.

J Clin Oncol. 2014 Jan 20;32(3):206-11. doi: 10.1200/JCO.2013.49.8386. Epub 2013 Dec 2.

17.

Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.

Dalton JT, Taylor RP, Mohler ML, Steiner MS.

Curr Opin Support Palliat Care. 2013 Dec;7(4):345-51. doi: 10.1097/SPC.0000000000000015. Review.

PMID:
24189892
18.

Estrogen regulates histone deacetylases to prevent cardiac hypertrophy.

Pedram A, Razandi M, Narayanan R, Dalton JT, McKinsey TA, Levin ER.

Mol Biol Cell. 2013 Dec;24(24):3805-18. doi: 10.1091/mbc.E13-08-0444. Epub 2013 Oct 23.

19.

Effect of para halogen modification of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides on metabolism and clearance.

Kim J, Coss CC, Dalton JT.

Arch Pharm Res. 2014 Nov;37(11):1464-76. doi: 10.1007/s12272-013-0258-4. Epub 2013 Oct 9.

PMID:
24105418
20.

Absorption, distribution, metabolism and excretion of the novel SARM GTx-024 [(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide] in rats.

Kim J, Wang R, Veverka KA, Dalton JT.

Xenobiotica. 2013 Nov;43(11):993-1009. doi: 10.3109/00498254.2013.788233. Epub 2013 Apr 22.

PMID:
24074268
Items per page

Supplemental Content

Loading ...
Write to the Help Desk